MASTROCOLA, Raffaella
 Distribuzione geografica
Continente #
NA - Nord America 10.614
EU - Europa 5.690
AS - Asia 5.455
SA - Sud America 752
AF - Africa 113
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 16
Totale 22.686
Nazione #
US - Stati Uniti d'America 10.407
CN - Cina 2.108
SG - Singapore 1.925
IT - Italia 1.454
SE - Svezia 640
BR - Brasile 597
DK - Danimarca 550
IE - Irlanda 548
DE - Germania 501
FR - Francia 379
VN - Vietnam 363
FI - Finlandia 354
GB - Regno Unito 307
UA - Ucraina 273
KR - Corea 216
JP - Giappone 173
PL - Polonia 145
AT - Austria 126
IN - India 121
HK - Hong Kong 118
CA - Canada 116
ID - Indonesia 83
ES - Italia 79
TR - Turchia 73
BE - Belgio 71
MX - Messico 71
AR - Argentina 60
NL - Olanda 53
RU - Federazione Russa 49
TW - Taiwan 44
AU - Australia 41
BD - Bangladesh 37
IQ - Iraq 37
ZA - Sudafrica 28
RO - Romania 25
EG - Egitto 23
GR - Grecia 22
VE - Venezuela 22
PH - Filippine 20
CL - Cile 19
CH - Svizzera 18
CZ - Repubblica Ceca 18
SA - Arabia Saudita 18
MA - Marocco 17
NO - Norvegia 17
CO - Colombia 15
EC - Ecuador 14
EU - Europa 14
SN - Senegal 14
IL - Israele 13
IR - Iran 13
TH - Thailandia 13
KE - Kenya 12
UZ - Uzbekistan 12
PE - Perù 11
HU - Ungheria 10
PK - Pakistan 10
BY - Bielorussia 9
JO - Giordania 9
KZ - Kazakistan 9
LT - Lituania 8
PT - Portogallo 7
PY - Paraguay 7
MY - Malesia 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
MO - Macao, regione amministrativa speciale della Cina 5
AZ - Azerbaigian 4
UY - Uruguay 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CR - Costa Rica 3
CY - Cipro 3
HR - Croazia 3
JM - Giamaica 3
NP - Nepal 3
NZ - Nuova Zelanda 3
RS - Serbia 3
A1 - Anonimo 2
AM - Armenia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
LB - Libano 2
LU - Lussemburgo 2
MG - Madagascar 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
Totale 22.664
Città #
Ann Arbor 1.993
Singapore 1.013
Chandler 944
Beijing 794
Ashburn 619
Dublin 545
Fairfield 473
Torino 473
Houston 435
Santa Clara 379
Wilmington 335
Woodbridge 244
Dearborn 229
Jacksonville 214
Seattle 203
Nyköping 197
Villeurbanne 195
San Jose 183
Turin 170
Cambridge 166
Medford 158
Los Angeles 146
Princeton 146
Redwood City 138
Pisa 135
Warsaw 134
Columbus 133
Helsinki 120
Dong Ket 106
Shanghai 106
Guangzhou 98
Vienna 91
The Dalles 86
Frankfurt am Main 85
Munich 82
Nanjing 80
Ho Chi Minh City 79
Hong Kong 76
New York 74
Nuremberg 74
Jakarta 73
Buffalo 72
Boston 67
Milan 64
Dallas 63
Boardman 58
Seoul 57
Hefei 55
Brussels 52
Rome 52
São Paulo 51
Fremont 50
Tokyo 46
Hanoi 45
Zhengzhou 42
Lauterbourg 38
Toronto 37
Düsseldorf 36
Phoenix 35
Xian 35
Wuhan 34
London 32
Chengdu 30
San Diego 30
Taipei 27
Shenyang 26
Washington 26
Kunming 24
Lappeenranta 24
Norwalk 24
Changsha 23
Turku 22
Chongqing 21
Hangzhou 21
Hebei 21
Rio de Janeiro 21
Ankara 20
Chicago 20
Ottawa 20
Silver Spring 20
Council Bluffs 19
Redondo Beach 19
Jinan 18
Stockholm 18
Atlanta 17
San Mateo 17
Verona 17
Baghdad 15
Montreal 15
Brooklyn 14
Chennai 14
Madrid 14
Nanchang 14
Santiago 14
Denver 13
Haiphong 13
Harbin 13
Istanbul 13
Manchester 13
Poplar 13
Totale 13.768
Nome #
Metaflammation: tissue-specific alterations of the NLRP3 inflammasome platform 1.346
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation 548
Combining doxorubicin-nanobubbles and shockwaves for Anaplastic thyroid cancer treatment: Preclinical study in a xenograft mouse model 489
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study 432
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways 378
Combined untargeted and targeted fingerprinting by comprehensive two-dimensional gas chromatography: revealing fructose-induced changes in mice urinary metabolic signatures 360
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice 359
Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR- agonism correlates with impaired NLRP3 inflammasome activation 351
A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice 351
Dysregulation of SREBP2 induces BACE1 expression. 336
Advanced glycation end-products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose drinking mice 328
Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle. 328
Hippocampal heat shock protein 25 expression in streptozotocin-induced diabetic mice. 320
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury? 320
Alpha-2A Adrenoceptor Agonist Guanfacine Restores Diuretic Efficiency in Experimental Cirrhotic Ascites: Comparison with Clonidine 311
Dietary sugars and endogenous formation of advanced glycation endproducts: Emerging mechanisms of disease 284
Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice 282
High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR- δ Agonism. 277
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts 277
Variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal muscles. 274
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data 272
Exacerbation of myocardial ischemia/reperfusion injury induced by high-fat-high-fructose (HFHF) diet: Role of NLRP3 inflammasome 267
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 263
SALIVAGE – EU JPI Project The “form” makes the difference: comprehensive two‐dimensional gas chromatography as highly informative fingerprinting tool to study the impact of fructose formulation on mice’s microbiota and its volatile metabolome signatures 262
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy 241
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 235
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons 232
A LIPIDOMIC STUDY OF HIGH-FAT DIET TREATED MICE. 226
Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle 226
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 224
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 222
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice 215
Pyridoxamine prevents diet-induced insulin resistance through the regulation of ceramide/sphingosine/sphingosine-1-phosphate equilibrium in mice liver 215
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation 212
Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643 210
Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. 207
A nonerythropoietic peptide analog of erythropoietin decreases susceptibility to diet-induced insulin resistance 207
Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes 202
Advanced glycation end products (AGEs) as pathology biomarkers: microwave assisted synthesis and biological quantitative analysis by LC-FTMS 196
Fructose-Derived Advanced Glycation End-Products Evoke Skeletal Muscle Damage in Mice by Multiple Interference with SCAP-SREBP Pathway 195
Calcium receptors located in fibrotic septa: a new target to reduce portal pressure in liver cirrhosis 194
Effects of Vitamin D on insulin resistance and myosteatosis in diet-induced obese mice 192
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction 191
Effects of CB1 Blockade In Experimental Diabetic Nephropathy 187
Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. 187
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction 180
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 179
Il blocco del recettore CB1 nella nefropatia diabetica sperimentale 178
AGEs and neurodegeneration: the Nrf2/glyoxalase-1 interaction. 173
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation 170
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 163
Dynamics of sodium retention in preascitic cirrhotic rats assessed through parathyroid hormone injection. 160
Inhibition of chymase-dependent production of kidney angiotensin II improves renal sodium handling and prevents ascites in experimental liver cirrhosis 158
Dose-dependecy of clonidine's effects in ascitic cirrhotic rats: Comparison with α1-adrenergic agonist midodrine. 155
Dietary advanced glycation endproducts in the mechanisms linking proteins glycosylation pattern, microbiota, and metabolic inflammation 155
AGEs up-regulates BACE1 through their interaction with RAGE and NFkB activation. 153
Inflammatory signaling and insulin resistance caused by sugar intake: modulation by PPAR-δ agonism 153
Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems 151
Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver. 150
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 149
Effects of empagliflozin in a murine model of diet-induced insulin resistance: A role for NLRP3 inflammasome inhibition? 149
Baricitinib counteracts metaflammation protecting against diet-induced metabolic abnormalities in mice 149
Pathogenesis of Solute-Free Water Retention in Experimental Ascitic Cirrhosis: Is Vasopressin the Only Culprit? 148
AGEs induce alterations of sphingolipids metabolism in the liver of genetically- and diet-induced diabetic mice 146
MicroRNA and microvascular complications of diabetes 141
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation 140
Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective 136
Advanced Glycation End-Products Promote Lipogenesis in Liver of Fructose-Drinking Mice 133
KRIT1/CCM1 Loss-of-function Mutations Impair Anti-glycative and Anti-oxidant Systems Worsening High Fructose Diet-induced Hepatic Dismetabolism 131
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis 130
Considerable aquaretic effects in experimental ascitic cirrhosis achieved through blunting of adrenergic function with α2A adrenergic receptor agonists 130
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress 127
Identification of risk factors and biomarkers of diagnostic and prognostic value associated with clinical progression and severity of cerebral cavernous malformations 127
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 126
Inhibition of AGEs by pyridoxamine prevents diet-induced systemic inflammation and skeletal muscle insulin resistance by restoring SphK/S1P3/RhoA signalling 120
Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose 118
Anti-Glycation Properties of Zinc-Enriched Arthrospira platensis (Spirulina) Contribute to Prevention of Metaflammation in a Diet-Induced Obese Mouse Model 117
Cannabinoid Receptors in Diabetic Kidney Disease 116
In experimental ascitic cirrhosis reduction of adrenergic function by means of α2A adrenergic receptor agonists has considerable aquaretic effects 116
Anti-inflammatory and anti-glycative properties of zinc-enriched spirulina in diet-induced obese/diabetic mice 115
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 114
Local renin–angiotensin system in the kidney of ascitic cirrhosis: An innocent bystander or a major protagonist? 113
Dehydroepiandrosterone in diabetic rats: protection against NFkB activation. 112
KRIT1/CCM1 loss-of-function impairs advanced glycation endproducts receptors and detoxification and worsens fructose diet-induced hepatic dysmetabolism 111
KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance 110
Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice 110
Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. 109
Vitamin D improves insulin sensitivity and myosteatosis in a model of diet-induced insulin resistance 106
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells 103
Intrahepatic renin-angiotensin system and liver cirrhosis: an updated reappraisal. 103
Oxidative and nitrosative stress in brain mitochondria of diabetic rats 103
High-fructose corn syrup (HFCS) diet induces an NLRP-3 inflammasome-mediated response in the kidney: protection by PPARb/d agonist 101
Miosyn switch in cardiac tissue of diabetic rats: role of oxidative stress. 99
Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis 97
Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus 97
Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes 94
Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats 94
In experimental liver cirrhosis impaired secretion of renalase into blood may lead to organ damage and sympathetic overactivity 93
Genetic deletion of RAGE in db/db mice interferes in the liver with other AGE-receptors and AGE-detoxifying systems sustaining lipogenesis and inflammation 93
Diabetes and muscle wasting: regulatory effect of dehydroepiandrosterone. 89
Totale 20.524
Categoria #
all - tutte 67.487
article - articoli 0
book - libri 0
conference - conferenze 25.597
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.295 0 0 0 0 0 0 154 129 259 197 124 432
2021/20223.286 283 245 257 327 267 220 298 296 163 133 423 374
2022/20232.827 293 237 94 295 242 655 199 205 342 57 127 81
2023/20241.248 141 201 80 67 96 136 52 108 15 96 108 148
2024/20253.424 35 220 155 294 657 236 137 252 515 221 242 460
2025/20263.450 618 190 359 740 735 352 456 0 0 0 0 0
Totale 23.300